Why IMU is a multi multi bagger, page-27945

@Anydaynow

that is a fair question, that I have answered before but happy to answer again.

I have been clear and shared previously that I am essentially sold out of IMU since 2022 except for a handful of shares to hopefully qualify for any future SPP. Similar to the IMU SPP I took up in 2023, which was very poorly taken up by the market. My holding of IMU is less than $ 300 worth and getting smaller due to the dropping sp.

To be clear, have no interest in buying any IMU shares on market no matter how low it goes. I only said that if you are a holder now of IMU, I would sell now and potentially buy back after the CR. My only next entry into IMU is via a discounted SPP with free options (if it happens again like in 2023).

I am not short iMU at present. However, I was short IMU from 5.1c just recently but closed that short (for no profit) not long after opening it because I felt it was easier to profit on the long side in multiple other ASX biotech opportunities than short IMU. Short IMU equals a maximum of 1x profit, but long other biotechs has multiple bags of upside. If I had more capital, and less other long ASX biotech opportunities, I would certainly still be short IMU.

Hence my Sentiment of “Sell” and position of “held” is accurate.